Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michele Dicataldo
Observed name:
M. Dicataldo
Institution:
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
Observed institutions:
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino,
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Istituto di Ematologia di Bologna,
University of Bari Aldo Moro,
University of Bologna
ORCID:
0000-0003-0385-9040
Observed ORCID:
0000-0003-0385-9040
OpenAlex ID:
A5018988910
CAR+ extracellular vesicles predict ICANS in patients with B cell lymphomas treated with CD19-directed CAR T cells
2024
·
Gianluca Storci
, Francesco De Felice
, et al.
·
Journal of Clinical Investigation
·
38
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience
2021
·
Beatrice Casadei
, Lisa Argnani
, et al.
·
Cancers
·
37
PDF
Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity
2021
·
Umberto Pensato
, Giulia Amore
, et al.
·
Journal of Neurology
·
31
PDF
STAT3, tumor microenvironment, and microvessel density in diffuse large B cell lymphomas
2019
·
Roberto Tamma
, Giuseppe Ingravallo
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
30
Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review
2022
·
Umberto Pensato
, Lorenzo Muccioli
, et al.
·
Journal of Neurology
·
27
PDF
Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity
2023
·
Serena De Matteis
, Michele Dicataldo
, et al.
·
Frontiers in Immunology
·
17
Prognostic Role of CDKN2A Deletion and p53 Expression and Association With MIPIb in Mantle Cell Lymphoma
2023
·
Francesco Gaudio
, Michele Dicataldo
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
11
The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
2022
·
Enrico Maffini
, Margherita Ursi
, et al.
·
Frontiers in Oncology
·
10
PDF
A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation
2023
·
Gabriella Chirumbolo
, Michele Dicataldo
, et al.
·
Transplantation and Cellular Therapy
·
9
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients
2023
·
Gianluca Storci
, Francesco Barbato
, et al.
·
Frontiers in Immunology
·
8
Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia
2025
·
Martina Barone
, Agnese Patuelli
, et al.
·
International Journal of Molecular Sciences
·
4
PDF
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia: Results of a Single-Center Study
2024
·
Davide Stella
, Jessica Gill
, et al.
·
Hematology Reports
·
3
Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient
2022
·
Ginevra Lolli
, Margherita Ursi
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
3
Longitudinal Changes of Ocular Surface Microbiome in Patients Undergoing Hemopoietic Stem Cell Transplant (HSCT)
2023
·
Suzanne Clougher
, Marco Severgnini
, et al.
·
Journal of Clinical Medicine
·
2
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy
2022
·
Serena De Matteis
, Beatrice Casadei
, et al.
·
Frontiers in Immunology
·
2
PDF
Correction to: Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review
2022
·
Umberto Pensato
, Lorenzo Muccioli
, et al.
·
Journal of Neurology
·
2
PDF
Assessment of CMV infection in allo-HSCT recipients undergoing LMV prophylaxis by using an implemented diagnostic protocol to identify active viral replication
2026
·
Giulia Piccirilli
, Michele Dicataldo
, et al.
·
Antiviral Research
·
1
Predicting ICANS by means of plasma CAR‐T cell derived extracellular vesicles in patients undergoing infusion of anti‐CD19 CAR‐T cells
2023
·
F. De Felice
, G. Storci
, et al.
·
Hematological Oncology
·
1
PDF
Old age: the crown of life, our play's last act. Question and answers on older patients undergoing allogeneic hematopoietic cell transplantation
2022
·
Enrico Maffini
, Moreno Festuccia
, et al.
·
Current Opinion in Hematology
·
1
Integrating new and “old” cellular therapies in the evolving landscape of relapsed or refractory large B-cell lymphoma
2026
·
Enrico Amaducci
, Michele Clerico
, et al.
·
Frontiers in Oncology
PDF
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas
2021
·
Francesca Bonifazi
, Irene Defrancesco
, et al.
·
Bone Marrow Transplantation
Show more works
View as search
Works count:
22
Citation count:
237
H-index:
9
I10-index:
8
Year
Topic
Type